New study finds no evidence linking paracetamol use during pregnancy to autism or ADHD

Date:

Share this article:

Del denne artikel:

A sweeping analysis found no convincing evidence that taking paracetamol during pregnancy increases the risk of neurodevelopmental disorders in children.

For years, paracetamol has been considered the safest pain relief option during pregnancy.

Yet confusion grew in 2025 after public warnings suggested that taking the common painkiller might raise the risk of autism or ADHD in children.

Health authorities around the world quickly pushed back, saying the claim was unsupported by solid evidence.

Still, the debate left many parents uncertain about what to believe.

Also read: Tiny implant eliminates bladder cancer in 82% of patients

Nine systematic reviews

According to a recent umbrella review published in the British Medical Journal (BMJ), researchers examined hundreds of scientific papers investigating the potential link between prenatal paracetamol use and neurodevelopmental outcomes.

After filtering for quality, only nine systematic reviews met the criteria, covering 40 original studies.

The analysis revealed major weaknesses in much of the previous research.

Many studies failed to control for factors such as family genetics, maternal health, or environmental influences. Others used inconsistent methods or incomplete data.

Also read: Dry cleaning chemical linked to higher risk of liver damage, study finds

When the strongest studies were isolated, especially those comparing siblings within the same families, the suggested connection between paracetamol use and developmental disorders disappeared entirely.

What it means for expectant mothers

The BMJ review concludes that there is no reliable evidence showing that paracetamol causes autism or ADHD when taken during pregnancy.

Researchers noted that earlier signals of risk were likely due to study bias rather than any true biological effect.

Medical experts continue to advise that pregnant women use paracetamol only when necessary and at the lowest effective dose, but the findings offer reassurance for millions who rely on it for pain or fever relief.

Also read: Research suggests home cooking may be the key to weight loss

Sources: News-medical, and British Medical Journal.

Also read: Eating spinach the wrong way can harm your health

This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.

Other articles

New diabetes pill shows 57% lower death risk than insulin in major trial, but there is a catch

A major clinical trial involving nearly 2,750 people with type 2 diabetes has revealed surprising results for a new daily pill. Patients taking the medication lost weight, achieved better blood sugar control and had fewer deaths than those receiving insulin injections. However, scientists warn that the most dramatic finding needs further confirmation.

Struggling to sleep? Major study links insomnia to a 26% higher stroke risk

A major scientific review involving millions of people has uncovered a concerning connection between insomnia and serious health problems. Researchers found a 26% higher relative risk of stroke and 28% higher odds of hospitalization among people with insomnia, raising new questions about the long-term consequences of poor sleep.

New AI tool can predict migraine risk a day early, and the biggest clue surprised researchers

An AI-powered tool has achieved 91.2% precision in predicting next-day migraine risk, according to a study involving more than 53,000 people. But the most reliable warning sign was not nausea, fatigue or sensitivity to light. It was something much simpler.

A blood test promises to detect over 50 cancers early but a major trial has revealed a problem

A revolutionary blood test designed to detect more than 50 types of cancer has failed to achieve its main goal in a trial involving over 142,000 people. Researchers did find some encouraging results, but the findings raise important questions about how reliable the test really is.

New diabetes pill shows 57% lower death risk than insulin in major trial, but there is a catch

A major clinical trial involving nearly 2,750 people with type 2 diabetes has revealed surprising results for a new daily pill. Patients taking the medication lost weight, achieved better blood sugar control and had fewer deaths than those receiving insulin injections. However, scientists warn that the most dramatic finding needs further confirmation.

Struggling to sleep? Major study links insomnia to a 26% higher stroke risk

A major scientific review involving millions of people has uncovered a concerning connection between insomnia and serious health problems. Researchers found a 26% higher relative risk of stroke and 28% higher odds of hospitalization among people with insomnia, raising new questions about the long-term consequences of poor sleep.

New AI tool can predict migraine risk a day early, and the biggest clue surprised researchers

An AI-powered tool has achieved 91.2% precision in predicting next-day migraine risk, according to a study involving more than 53,000 people. But the most reliable warning sign was not nausea, fatigue or sensitivity to light. It was something much simpler.